Celtrix's SomatoKine Demonstrates Positive Effects in Diabetes Patients

Posted by Bill F. on February 26, 1999 at 03:43:44:

Must read, very interesting and promising drug. See the link for the full release.

http://biz.yahoo.com/bw/990225/ca_celtrix_1.html

SAN JOSE, Calif.--(BW HealthWire)--Feb. 25, 1999--Celtrix Pharmaceuticals, Inc. (Nasdaq:CTRX - news) announced today the results of its Phase IIA clinical trial in patients with Type 1 diabetes. The final data reveal significant treatment results in several key measurements: in patients who received SomatoKineŽ (IGF-I/BP3) treatment, the average daily insulin requirement decreased by 49% and average daily blood glucose levels decreased by 23% from the levels associated with conventional insulin therapy. SomatoKine also demonstrated that total serum cholesterol was reduced by 12%.

Follow Ups:

• Re: Celtrix's SomatoKine Demonstrates Positive Effects in Diabetes Patients L 20:45:23 2/28/99 (0)
• Re: Celtrix's SomatoKine Demonstrates Positive Effects in Diabetes Patients Al Gordon 20:50:18 2/26/99 (4)
  • Re: Celtrix's SomatoKine Demonstrates Positive Effects in Diabetes Patients Jim Lovejoy 02:32:46 2/27/99 (3)
    • Celtrix's SomatoKine and Minimed, etc. Bill F. 05:36:15 2/27/99 (2)
      • Re: Celtrix's SomatoKine and Minimed, etc. Sue Huson 15:24:10 2/27/99 (1)
        • Re: Celtrix's SomatoKine and Minimed, etc. Renee 16:35:58 2/27/99 (0)

Post a Followup